As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...

AliveCor has received clearance for its portable ECG to calculate a patient’s QTc Interval. This FDA action follows the enforcement policy for non-invasive devices issued by the agency in March 2020 ...

The diagnostics advisory committee considered evidence on KardiaMobile 6L for measuring QT interval from several sources, including an early value assessment report, cost and resource use report and ...

AliveCor is also offering a service called InstantQT™ to assist in measuring QT intervals through an FDA-cleared, ECG processing software. The Food and Drug Administration (FDA) has cleared the ...

Individuals with spinal cord injury (SCI) demonstrate an elevated risk for cardiac arrhythmias as indicated by an elevated QT-variability index (QTVI). The methodology measuring the QTVI, however, is ...

Uncertainty remains regarding the value of heart-rate-corrected QT interval (QTc) prolongation on electrocardiogram for predicting cardiovascular disease (CVD), particularly among Asian populations.

Please provide your email address to receive an email when new articles are posted on . AliveCor announced it received FDA 510(k) clearance for its mobile, handheld ECG device for the calculation of a ...

A machine learning model was more effective at detecting congenital long QT syndrome on resting ECGs than manual measurement of QT intervals by arrhythmia experts, in a new study. Researchers ...

ADInstruments has announced that PowerLab systems are being used to establish the zebrafish as a model for assessing drug effects on cardiac function, using QT prolongation as a key indicator.

the effectiveness (diagnostic accuracy) of using KardiaMobile 6L to measure QT interval in adults having or about to have antipsychotic medications and the effect of the corrected QT interval (QTc) ...